Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Original Article

    Qualitative Phytochemical Analysis and Antibacterial Activity Evaluation of Indian Terminalia spp. Against the Pharyngitis Causing Pathogen Streptococcus pyogenes.

    wadmin2By wadmin2January 5, 2016Updated:August 11, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Mitchell Henry Wright,a Megan Sarah Jean Arnold,b Cameron Jay Lee,a Reece Courtney,a,c Anthony Carlson Greene,a Ian Edwin Cock,a,c*
    aSchool of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Queensland 4111, AUSTRALIA.
    bEskitis Institute for Drug Discovery, Griffith University, Queensland, Australia, 46 Don Young Rd, Nathan, Queensland 4111, AUSTRALIA.
    cEnvironmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Queensland 4111, AUSTRALIA.

    Pharmacognosy Communications,2016,6,2,85-92.
    DOI:10.5530/pc.2016.2.6
    Published: January 2016
    Type: Original Article

    ABSTRACT

    Introduction: Streptococcus pyogenes is a gram-positive, pathogenic bacterium which causes a variety of diseases including streptococcal pharyngitis, impetigo and rheumatic heart disease, depending on which tissue it infects. Many Terminalia spp. have documented therapeutic properties as general antiseptics, inhibiting the growth of a wide variety of bacterial species. Methods: Solvent extracts were prepared using Indian Terminalia spp. with documented ethnobotanical usage to treat bacterial infections, or published antibacterial activity. The extracts were investigated by disc diffusion assay for the ability to inhibit the growth of a clinical strain of S. pyogenes. Their MIC values were determined to quantify and compare their efficacies. Toxicity was determined using the Artemia franciscana nauplii bioassay. Results: T. arjuna, T. catappa and T. chebula methanolic and ethyl acetate extracts displayed potent antibacterial activity in the disc diffusion assay against S. pyogenes. The T. catappa and T. chebula ethyl acetate extracts were particularly potent, with MIC values of 225 and 205 μg/mL respectively. All methanolic extracts were also potent growth inhibitors with MIC values of 268 μg/mL (T. arjuna methanolic extract), 425 μg/mL (T. catappa methanolic extract) and 300 μg/mL (T. chebula methanolic extract). The T. catappa hexane extract was also a potent S. pyogenes growth inhibitor (MIC 768 μg/mL). All other extracts were either ineffective or were of only low efficacy. Furthermore, all of the Indian Terminalia spp. extracts were nontoxic in the Artemia fransiscana bioassay, with LC50 values >1000 μg/mL. Conclusion: The potent growth inhibitory bioactivity of the methanolic and ethyl acetate T. arjuna, T. catappa and T. chebula extracts against S. pyogenes demonstrates their potential for the treatment and prevention of pharyngitis, impetigo and rheumatic heart disease. All extracts were nontoxic indicating their safety for therapeutic use.

    Key words: Terminalia arjuna, Terminalia catappa,Terminalia chebula pharyngitis, Impetigo, Rheumatic heart disease, Antibacterial activity, Ayurveda.

    Download PDF

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up